These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10488878)

  • 21. Haemophilus influenzae type b vaccine in Papua New Guinea: what can we expect, and how should we determine priority for child health interventions?
    Duke T
    P N G Med J; 1999; 42(1-2):1-4. PubMed ID: 11061000
    [No Abstract]   [Full Text] [Related]  

  • 22. Translational research to assist policy decisions about introducing new vaccines in developing countries.
    Clemens JD; Jodar L
    J Health Popul Nutr; 2004 Sep; 22(3):223-31. PubMed ID: 15609774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Considerations for combination vaccine development and use in the developing world.
    Di Fabio JL; de Quadros C
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S340-5. PubMed ID: 11709770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age- and cause-specific childhood mortality in Lombok, Indonesia, as a factor for determining the appropriateness of introducing Haemophilus influenzae type b and pneumococcal vaccines.
    Nelson CM; Sutanto A; Gessner BD; Suradana IG; Steinhoff MC; Arjoso S
    J Health Popul Nutr; 2000 Dec; 18(3):131-8. PubMed ID: 11262765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hib vaccine introduced in The Gambia.
    Wenger J
    Afr Health; 1997 Nov; 20(1):13, 15. PubMed ID: 12348371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public engagement with science? Local understandings of a vaccine trial in the Gambia.
    Fairhead J; Leach M; Small M
    J Biosoc Sci; 2006 Jan; 38(1):103-16. PubMed ID: 16266443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical guidelines on HIV vaccine research.
    AIDS Read; 2000 Apr; 10(4):207. PubMed ID: 10808598
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins.
    Lee YC; Newport MJ; Goetghebuer T; Siegrist CA; Weiss HA; Pollard AJ; Marchant A;
    Vaccine; 2006 Jun; 24(25):5335-40. PubMed ID: 16701924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Very good effect of Hib vaccination in Kenya].
    Gjersvik P
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2554. PubMed ID: 17042086
    [No Abstract]   [Full Text] [Related]  

  • 31. Nature abhors vacuum, but public health is loving it: the sustained decrease in the rate of invasive Haemophilus influenzae disease.
    Butler JC
    Clin Infect Dis; 2005 Mar; 40(6):831-3. PubMed ID: 15736016
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process.
    Garpenholt O; Fredlund H; Timpka T
    Scand J Public Health; 2001 Dec; 29(4):271-8. PubMed ID: 11775783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
    Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
    Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.
    Black S; Greenberg DP
    Expert Rev Vaccines; 2005 Dec; 4(6):793-805. PubMed ID: 16372875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ethics of research in developing countries.
    Handsfield HH
    N Engl J Med; 2000 Aug; 343(5):363. PubMed ID: 10928893
    [No Abstract]   [Full Text] [Related]  

  • 36. The ethics of research in developing countries.
    Greco DB
    N Engl J Med; 2000 Aug; 343(5):362; author reply 363. PubMed ID: 10928889
    [No Abstract]   [Full Text] [Related]  

  • 37. The ethics of research in developing countries.
    Hearst N
    N Engl J Med; 2000 Aug; 343(5):362-3. PubMed ID: 10928891
    [No Abstract]   [Full Text] [Related]  

  • 38. Ethical issues in tuberculosis vaccine trials.
    Snider DE
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S271-5. PubMed ID: 10875798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.
    Huebner RE; Nicol M; Mothupi R; Käyhty H; Mbelle N; Khomo E; Klugman KP
    Vaccine; 2004 Dec; 23(6):802-6. PubMed ID: 15542205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. World Pneumonia Day: fighting pneumonia with safe and affordable vaccines.
    Dagan R; Poland G
    Vaccine; 2010 Nov; 28(48):7577-8. PubMed ID: 20932497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.